Bladder cancer
Conditions
Interventions
Transurethral cystectomy for tumours group:None
Radical cystectomy group:None
Comprehensive bladder preservation therapy group:None
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients must be >= 18 years of age; 2. Patients with pathologically diagnosed malignant tumours of the bladder; 3. Patients who have received a standardised bladder cancer treatment protocol; 4. Patients with 3 or more years of follow-up information; 5. The major organs (heart, liver, lungs, kidneys) function is basically normal, PS score: 0-2; 6. Patients must have comprehensive clinical data: (1) Imaging data: including CTU or MRI. (2) Pathological data: including full-field images of tissue sections and pathology reports. (3) Clinical data: including basic patient information (age, gender), medical history, treatment regimen, assessment of efficacy (e.g., RECIST criteria), and record of adverse reactions.
Exclusion criteria
Exclusion criteria: 1. Exclude patients with concurrent history of other malignancies; 2. Exclude patients who have recently received other experimental treatments; 3. Exclude patients with serious comorbidities (e.g., heart disease, liver or kidney insufficiency, etc.) that may affect the outcome of treatment; 4. Exclude patients with all missing imaging data or pathological data or poor image quality.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence free survival;Progression-free survival;Overall survival; | — |
Countries
China
Contacts
Public ContactHaitao Liu
Shanghai General Hospital
Outcome results
None listed